Channing Capital Management’s AbbVie ABBV Stock Holding History

Channing Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.3M	Buy	64,578 +3,016	+5%	+$649K	0.37%	48
2026 Q1	$13.4M	Buy	61,562 +4,503	+8%	+$999K	0.34%	46
2025 Q4	$13M	Buy	57,059 +1,412	+3%	+$322K	0.34%	49
2025 Q3	$12.9M	Buy	55,647 +5,302	+11%	+$1.08M	0.34%	48
2025 Q2	$9.35M	Buy	50,345 +2,270	+5%	+$422K	0.26%	72
2025 Q1	$10.1M	Sell	48,075 -12,723	-21%	-$2.47M	0.3%	60
2024 Q4	$10.8M	Buy	60,798 +5,397	+10%	+$992K	0.29%	59
2024 Q3	$10.9M	Sell	55,401 -2,911	-5%	-$543K	0.28%	58
2024 Q2	$10M	Buy	58,312 +5,826	+11%	+$965K	0.27%	63
2024 Q1	$9.56M	Sell	52,486 -6,500	-11%	-$1.12M	0.26%	69
2023 Q4	$9.14M	Buy	58,986 +3,152	+6%	+$460K	0.27%	63
2023 Q3	$8.32M	Sell	55,834 -6,831	-11%	-$1M	0.27%	62
2023 Q2	$8.44M	Buy	62,665 +9,218	+17%	+$1.35M	0.26%	65
2023 Q1	$8.52M	Sell	53,447 -15,984	-23%	-$2.44M	0.27%	73
2022 Q4	$11.2M	Buy	+69,431	New	+$10.6M	0.36%	69
2019 Q1	–	Sell	-62,619	Closed	-$5.77M	–	107
2018 Q4	$5.77M	Sell	62,619 -26,719	-30%	-$2.35M	0.29%	82
2018 Q3	$8.45M	Buy	89,338 +25,686	+40%	+$2.44M	0.3%	72
2018 Q2	$5.9M	Buy	+63,652	New	+$6.22M	0.21%	87
2014 Q1	–	Sell	-32,615	Closed	-$1.72M	–	97
2013 Q4	$1.72M	Hold	32,615	–	–	0.11%	96
2013 Q3	$1.46M	Hold	32,615	–	–	0.11%	98
2013 Q2	$1.35M	Buy	+32,615	New	+$1.43M	0.12%	97

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Channing Capital Management's ABBV Position: Q2 2026 in Review

Channing Capital Management increased its AbbVie (ABBV) stake by 4.9% in Q2 2026, buying an estimated $649K and bringing the position to 64,578 shares worth $16.3M. The position accounts for 0.37% of the portfolio, ranked #48.

Channing Capital Management first reported a position in ABBV in Q2 2013 and has held it in 21 quarters since. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Channing Capital Management held 64,578 shares of AbbVie worth $16.3M as of Q2 2026.
Channing Capital Management bought 3,016 AbbVie shares in Q2 2026, an estimated $649K.
AbbVie made up 0.37% of Channing Capital Management's portfolio in Q2 2026, its #48 holding.
Channing Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 21 quarters since.
4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Channing Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.